View by Specialty

Trending

Colonoscopy
March 04, 2025
3 min read
Save

US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’

Scleroderma News

SPONSORED CONTENT
March 10, 2025
2 min read
Save
‘There is a whole other world out there’: Beyond CAR-T therapies for autoimmune diseases

‘There is a whole other world out there’: Beyond CAR-T therapies for autoimmune diseases

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has several limitations that may be overcome instead through bispecific T-cell-engaging antibodies, according to a speaker.

SPONSORED CONTENT
February 18, 2025
2 min read
Save

FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion

FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell therapy that may bypass lymphodepletion, paving the way for a phase 1 trial in lupus and other autoimmune diseases.

SPONSORED CONTENT
February 12, 2025
53 min listen
Save

Pulmonary hypertension and the rheumatologist, part 1: A bit of background

Pulmonary hypertension and the rheumatologist, part 1: A bit of background

In this series, we dive into what rheumatologists should know about pulmonary hypertension, starting an interview with Joseph Parambil, MD, where we learn about the disease, when to suspect and how to work up!

Trending

Colonoscopy
March 04, 2025
3 min read
Save

US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’

SPONSORED CONTENT
February 05, 2025
2 min read
Save

Low-dose steroids fail to improve skin fibrosis in early diffuse systemic sclerosis

Low-dose steroids fail to improve skin fibrosis in early diffuse systemic sclerosis

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse cutaneous systemic sclerosis, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
February 03, 2025
2 min read
Save

Menopausal hormone therapy may increase risks for lupus, systemic sclerosis

Menopausal hormone therapy may increase risks for lupus, systemic sclerosis

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of menopausal hormone therapy, according to data published in Rheumatology.

SPONSORED CONTENT
January 17, 2025
2 min read
Save

Medicare selects 15 drugs for second round of price negotiations, including semaglutide

Medicare selects 15 drugs for second round of price negotiations, including semaglutide

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.

SPONSORED CONTENT
January 16, 2025
3 min read
Save

Frailty in systemic sclerosis increases mortality risk nearly 10 times

Frailty in systemic sclerosis increases mortality risk nearly 10 times

Frailty among patients with systemic sclerosis significantly increases the risk for mortality by nearly 10-fold, but shows the potential to improve over time, according to data published in Clinical Rheumatology.

SPONSORED CONTENT
December 31, 2024
4 min read
Save

CAR T therapy for autoimmune disease exploded in 2024. Here’s what you may have missed

CAR T therapy for autoimmune disease exploded in 2024. Here’s what you may have missed

After first generating excitement in late 2022, this year was a bonanza for news about chimeric antigen receptor T-cell therapies for autoimmune rheumatic diseases.

SPONSORED CONTENT
December 18, 2024
1 min read
Save

CAR T therapy shows ‘no major hematotoxicites’ in autoimmune disease phase 1/2 study

CAR T therapy shows ‘no major hematotoxicites’ in autoimmune disease phase 1/2 study

WASHINGTON — A phase 1/2 study of CD19 chimeric antigen receptor T-cell therapy in lupus and other autoimmune diseases demonstrated significant response with minimal toxicities, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
December 17, 2024
2 min read
Save

CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis

CD19 CAR-T therapy yields long-term benefits in lupus, myositis, systemic sclerosis

WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over a period of up to 15 months in 35 patients with lupus, myositis and systemic sclerosis, according to data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails